Get access

Monoamine oxidase B inhibitors for early Parkinson's disease

  • Protocol
  • Intervention

Authors

  • AD Macleod,

  • CE Counsell,

    Clinical Senior Lecturer in Neurology, Corresponding author
    1. University of Aberdeen, Department of Medicine & Therapeutics, Aberdeen, UK
    • CE Counsell, Clinical Senior Lecturer in Neurology, Department of Medicine & Therapeutics, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. carl.counsell@abdn.ac.uk.

    Search for more papers by this author
  • N Ives,

  • R Stowe


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the evidence from randomised controlled trials for the efficacy and safety of long-term use of MAO-B inhibitors in patients with early Parkinson's disease.